Liver markers
In non-alcoholic steatohepatitis without diabetes, 800 IU/day improved liver histology in the PIVENS trial. It is the most positive vitamin E result in the modern literature, it applies to a specific diagnosis under specialist care, and it uses a dose with documented long-term risks.
Limited evidence. Early human work, or mostly lab and animal research.
View the 3 sources
- Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis.(opens in a new tab)
Randomised controlled trial · The New England journal of medicine · 2010 · PMID 20427778
- Vitamin E for people with non-alcoholic fatty liver disease.(opens in a new tab)
Meta-analysis · The Cochrane database of systematic reviews · 2024 · PMID 39412049
- Vitamin E (300 mg) in the treatment of MASH: A multi-center, randomized, double-blind, placebo-controlled study.(opens in a new tab)
Randomised controlled trial · Cell reports. Medicine · 2025 · PMID 39970876
Deep research mode adds each paper’s own conclusion and stated limitations.